{
    "code": "01008311",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01008311",
    "time": "2020-02-25 02:01:30",
    "許可證字號": "衛署藥製字第008311號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/05\/25",
    "發證日期": "64\/11\/27",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00100831107",
    "中文品名": "&quot;利達&quot; 利煩必新膠囊１５０公絲",
    "英文品名": "RIFAMPICIN CAPSULES 150MG &quot;LITA&quot;",
    "適應症": "肺結核、奈瑟氏腦膜炎球菌帶原者",
    "劑型": "130膠囊劑",
    "包裝": "50顆瓶裝 50顆盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0701010200  利達製藥股份有限公司",
        "申請商地址": "台中市大甲區中山路一段９０６號",
        "主製造廠": ""
    },
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812900100",
            "成分名稱": "RIFAMPIN (EQ TO RIFAMPICIN) (EQ TO RIMACTAN)",
            "含量描述": "(POTENCY)",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "01008311.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01008311&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "RIC-利煩必新膠囊150公絲-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01008311&Seq=003&Type=9"
        }
    ]
}